• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Dementia diagnosis underreporting is common and associated with reduced care engagement

byHannan MinhasandThomas Su
August 29, 2026
in Chronic Disease, Psychiatry
Reading Time: 3 mins read
Quick Take: Risk of rhabdomyolysis with donepezil compared with rivastigmine or galantamine
Share on FacebookShare on TwitterShare on LinkedIn

1. In this retrospective cohort study involving older adults with probable dementia and a claims-based diagnosis, underreporting of dementia was substantially more common than underreporting of other diagnosed chronic conditions. 

2. Dementia underreporting was associated with patient and care-delivery factors and with lower postdiagnosis care engagement and planning. 

Evidence Rating Level: 2 (Good)

Study Rundown: Early dementia diagnosis can provide patients and families with time to access support services, participate in medical decisions, and address future legal, financial, and care needs. However, these benefits are dependent on effective communication and understanding by the patient or caregiver. Diagnostic uncertainty, stigma, or difficulty recognizing cognitive impairment may create a gap between documentation in the medical record and patient awareness. Previous research has largely focused on dementia that remains clinically undiagnosed, with less known about underreporting among patients who already have a documented diagnosis. Hence, this population-based cohort study used Medicare-linked Health and Retirement Study data to examine dementia diagnosis underreporting among older adults with probable dementia. Overall, dementia underreporting was considerably more common than underreporting of arthritis, hypertension, diabetes, or depression and remained frequent after dementia onset. Underreporting was associated with social vulnerability, cognitive and functional characteristics, and the setting in which the diagnosis was documented. Patients who underreported dementia were also less likely to attend a problem-based medical visit, receive an influenza vaccination, or have a witnessed will or trust following diagnosis. Interpretation was limited by reliance on claims and self-reported diagnoses as well as the inability to distinguish specific contributions of stigma, inadequate disclosure, impaired recall, and diagnosis nonacceptance. Nonetheless, this study suggests that dementia detection should be accompanied by clear diagnostic disclosure and structured postdiagnosis support to translate early identification into actionable care. 

Click to read the study in JAMA

Relevant Reading: Underdiagnosis of Dementia: An Observational Study of Patterns in Diagnosis and Awareness in US Older Adults. 

RELATED REPORTS

Gabapentin (Neurontin) prescription for chronic low back pain in adults is associated with a higher risk of dementia

2 Minute Medicine Rewind October 12, 2026

Earlier menopause is associated with faster cognitive decline and greater late-life brain changes

In-Depth [retrospective cohort study]: This retrospective cohort study analyzed Health and Retirement Study survey waves from 1998 through 2020 linked with Medicare claims. Participants were adults 65 years of age or older who had probable dementia according to the validated Langa-Weir cognitive classification and a dementia diagnosis recorded in Medicare claims. A total of 3278 individuals contributed 6158 person-waves, with each person-wave representing one participant’s data at a particular survey assessment. Overall, 49.1% of person-waves involved adults 85 years of age or older, 69.5% involved women, and 69.1% involved non-Hispanic White adults. Additionally, 46.0% lived alone, 37.8% were dually eligible for Medicare and Medicaid, 55.5% used a proxy respondent, and 46.0% had received care from a dementia specialist. Underreporting was defined as not reporting that a physician had diagnosed dementia or a memory-related condition despite having a claims-based dementia diagnosis during the preceding 2-year survey interval. The adjusted proportion underreporting dementia was 42% among all respondents (95% confidence interval [CI], 40% to 43%) and 67% among self-respondents (95% CI, 64% to 69%). Among self-respondents, underreporting was lower for arthritis at 17% (95% CI, 15% to 18%), hypertension at 23% (95% CI, 21% to 24%), diabetes at 39% (95% CI, 37% to 41%), and depression at 46% (95% CI, 43% to 48%). Among self-respondents, living alone (odds ratio [OR], 1.65; 95% CI, 1.27 to 2.13), non-Hispanic Black race compared with non-Hispanic White race (OR, 1.42; 95% CI, 1.01 to 2.00), and a higher cognitive score (OR per point, 1.14; 95% CI, 1.11 to 1.18) were associated with greater odds of underreporting. In contrast, a dementia specialist visit (OR, 0.64; 95% CI, 0.50 to 0.82) was associated with lower odds. Underreporting was associated with lower odds of a postdiagnosis problem-based visit (OR, 0.70; 95% CI, 0.55 to 0.90; p=0.005), influenza vaccination (OR, 0.63; 95% CI, 0.51 to 0.77; p<0.001), and having a witnessed will or trust (OR, 0.70; 95% CI, 0.54 to 0.90; p=0.005). Sensitivity analyses using more stringent diagnostic definitions produced similar findings. Overall, these findings suggest an opportunity to improve diagnostic disclosure and postdiagnosis care engagement among persons with probable dementia.

Image: PD

©2026 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

Tags: advance care planning (ACP)dementiamedical claims
Previous Post

A landmark court ruling was associated with increased travel across state borders for abortion care

Next Post

2 Minute Medicine Rewind August 31, 2026

RelatedReports

Chronic Disease

Gabapentin (Neurontin) prescription for chronic low back pain in adults is associated with a higher risk of dementia

October 13, 2026
Weekly Rewinds

2 Minute Medicine Rewind October 12, 2026

October 12, 2026
Longevity

Earlier menopause is associated with faster cognitive decline and greater late-life brain changes

October 5, 2026
Neurology

Older married couples demonstrate domain-specific cognitive concordance 

August 28, 2026
Next Post
Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source

2 Minute Medicine Rewind August 31, 2026

Increasing maternal BMI linked to higher risk of cerebral palsy

Newer GLP-1 agents yield substantial weight loss in nondiabetic adults

Paternal factors associated with short interpregnancy interval

Higher parental vitamin B12 associated with fewer birth defects

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Artificial intelligence (AI)-powered mental health app demonstrated improved social well-being among users
  • Children with intellectual and developmental disabilities have increased risks of depression and anxiety
  • Gabapentin (Neurontin) prescription for chronic low back pain in adults is associated with a higher risk of dementia
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.